Starting treatment now with an approved medication, then reassessing in 2028, is the approach most obesity specialists recommend
What holds after months, after years, and after the molecule is stopped
Ironically, multiple treatment guidelines and algorithms periodically released to improve guidance may generate confusion into clinicians [20]
THEREFORE, clinical trial designers, investors, and regulators need to aim for more #clinicallyrelevant treatment target #endpoints beyond large magnitude wt loss, and also develop various drug #doses for the diverse intended populations and their different needs over time on their #weightmanagement journey
Understanding which symptoms warrant concern versus which require patience helps people persist through the adaptation phase
PlexusDx reviews your medical history, current medications, and weight loss goals to determine semaglutide eligibility and appropriate starting dose